ReviewSeminars in hematology2017
The use and impact of Twitter at medical conferences: Best practices and Twitter etiquette.
Review in Seminars in hematology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- Impact of a New Gynecologic Oncology Hashtag During Virtual-Only ASCO Annual Meetings: An X (Twitter) Social Network Analysis.JMIR medical education · 2024Article
- Social Media in Hip Arthroscopy Is an Underused Resource That Enhances Physician Online Reputation.Arthroscopy, sports medicine, and rehabilitation · 2022Article
- Netiquette for social media engagement for oncology professionals.Future oncology (London, England) · 2022Review
- Comprehensive analysis of Twitter usage during a major medical conference held virtually versus in-person.Insights into imaging · 2022Article
- Audience of Academic Otolaryngology on Twitter: Cross-sectional Study.JMIR medical education · 2021Article
- The Role and Impact of Social Media in Cardio-oncology During the COVID-19 Pandemic.Current oncology reports · 2021Review
- Advances in cancer research dissemination through the pandemic and beyond.Annals of oncology : official journal of the European Society for Medical Oncology · 2021Article
- Analysis of Cyberincivility in Posts by Health Professions Students: Descriptive Twitter Data Mining Study.JMIR medical education · 2021Article
- Next-Generation Scholarship: Rebranding Hematopathology Using Twitter: The MD Anderson Experience.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2021Article
- Tweeting from the Bench: Twitter and the Physician-Scientist Benefits and Challenges.Current hematologic malignancy reports · 2020Review
- Growth of the Digital Footprint of the Society of Critical Care Medicine Annual Congress: 2014-2020.Critical care explorations · 2020Article
- Leveraging Social Media for Cardio-Oncology.Current treatment options in oncology · 2020Review
- A Collaborative Framework Based for Semantic Patients-Behavior Analysis and Highlight Topics Discovery of Alcoholic Beverages in Online Healthcare Forums.Journal of medical systems · 2020Article
- Science and Social Media.Stem cells translational medicine · 2019Article
- Analysis of highly tweeted dental journals and articles: a science mapping approach.British dental journal · 2019Article
- Twitter Use in the Hematopoietic Cell Transplantation Community.Current hematologic malignancy reports · 2018Review
- Social Media in Hematology in 2017: Dystopia, Utopia, or Somewhere In-between?Current hematologic malignancy reports · 2017Review
- Rare Cancers and Social Media: Analysis of Twitter Metrics in the First 2 Years of a Rare-Disease Community for Myeloproliferative Neoplasms on Social Media-#MPNSM.Current hematologic malignancy reports · 2017Review
- Using Social Media at National Meetings in Hematology-Optimal Use, Tips, Strategies, and Limitations.Current hematologic malignancy reports · 2017Review
- Analysis of First-Year Twitter Metrics of a Rare Disease Community for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) on Social Media: #BPDCN.Current hematologic malignancy reports · 2017Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The use of social media, and in particular, Twitter, for professional use among healthcare providers is rapidly increasing across the world. One medical subspecialty that is leading the integration of this new platform for communication into daily practice and for information dissemination to the general public is the field of hematology/oncology. A growing amount of research in this area demonstrates that there is increasing interest among physicians to learn not only how to use social media for consumption of educational material, but also how to generate and contribute original content in one's interest/expert areas. One aspect in which this phenomenon has been highlighted is at the time of maximum new information presentation: at a major medical conference. Hematologists/oncologists are engaging regularly in one of the most common forms of social media, Twitter, during major medical conferences, for purposes of debate, discussion, and real-time evaluation of the data being presented. As interest has grown in this area, this article aims to review the new norms, practices, and impact of using Twitter at the time of medical conferences, and also explores some of the barriers and pitfalls that users are encountering in this emerging field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.